Avricore Health (AVCRF) Receivables (2009 - 2026)

Avricore Health (AVCRF) has reported Receivables for 18 consecutive years, with $39173.7 the latest figure, recorded in Q1 2026.

• In Q1 2026, Receivables rose 16.99% year-over-year to $39173.7; the TTM figure through Mar 2026 stood at $39173.7 (up 16.99% YoY), while the FY2025 annual figure was $26719.3, down 91.39% from the prior year.
• Receivables advanced to $39173.7 in Q1 2026 per AVCRF's latest filing, from $26770.3 in the prior quarter.
• Across five years, Receivables topped out at $583946.8 in Q4 2022 and bottomed at $1540.3 in Q4 2023.
• Historically, Receivables has averaged $191843.0 across 5 years, with a median of $173600.4 in 2023.
• Annual changes were most pronounced in 2023 — Receivables plunged 99.74% — and 2024, when it jumped 19647.32%.
• Avricore Health's Receivables stood at $583946.8 in 2022, then tumbled by 99.74% to $1540.3 in 2023, then jumped by 19647.32% to $304172.2 in 2024, then tumbled by 91.2% to $26770.3 in 2025, then jumped by 46.33% to $39173.7 in 2026.
• Business Quant data shows AVCRF's Receivables at $39173.7 in Q1 2026, $26770.3 in Q4 2025, and $15076.9 in Q3 2025.